SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-143397
Filing Date
2017-04-27
Accepted
2017-04-27 17:20:04
Documents
5
Effectiveness Date
2017-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A d326605ddefa14a.htm DEFA14A 18287
2 GRAPHIC g326605g32e94.jpg GRAPHIC 114359
3 GRAPHIC g326605g37h61.jpg GRAPHIC 107458
4 GRAPHIC g326605g40m36.jpg GRAPHIC 227401
5 GRAPHIC g326605g65u03.jpg GRAPHIC 294879
  Complete submission text file 0001193125-17-143397.txt   1036578
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50768 | Film No.: 17790334
SIC: 2834 Pharmaceutical Preparations